Synthesis of New Dihydroindeno[1,2-<i>c</i>]isoquinoline and Indenoisoquinolinium Chloride Topoisomerase I Inhibitors Having High in Vivo Anticancer Activity in the Hollow Fiber Animal Model
Muthusamy Jayaraman(Forma Therapeutics (United States)), Mark Cushman(University of Indianapolis), Yves Pommier(National Cancer Institute), Brian M. Fox(Purdue University West Lafayette), Glenda Kohlhagen(Purdue University West Lafayette), Melinda G. Hollingshead(National Cancer Institute)
Cited by 95
Related Papers
Rational design of cationic lipids for siRNA delivery
|Nature Biotechnology|2010|1.8k
The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs
|Nature Nanotechnology|2019|1.6k
Maximizing the Potency of siRNA Lipid Nanoparticles for Hepatic Gene Silencing In Vivo**
|Angewandte Chemie International Edition|2012|1.2k
Targeted Delivery of RNAi Therapeutics With Endogenous and Exogenous Ligand-Based Mechanisms
|Molecular Therapy|2010|1.2k
A combinatorial library of lipid-like materials for delivery of RNAi therapeutics
|Nature Biotechnology|2008|1.2k